| Overall mortality in Cox regression | Cancer-specific mortality in Cox regression | ||||||
---|---|---|---|---|---|---|---|---|
Univariable COX | Multivariable cox | Univariable cox | Multivariable cox | |||||
HR (95%CI) | P | HR (95%CI) | P | HR (95%CI) | P | HR (95%CI) | P | |
Sex | ||||||||
 Female(n = 145) | Reference | 0.325 |  |  | Reference | 0.41 |  |  |
 Male(n = 205) | 1.122 (0.892–1.413) |  |  |  | 1.105 (0.871–1.402) |  |  |  |
Race | ||||||||
 White(n = 278) | Reference | .080 |  |  | Reference | .182 |  |  |
 Black(n = 40) | 1.357 (0.961–1.917) | 0.083 |  |  | 1.333 (0.930–1.908) | 0.117 |  |  |
 Other(n = 32) | 0.773 (0.515–1.162) | 0.216 |  |  | 0.847 (0.563–1.274) | 0.425 |  |  |
Age | ||||||||
 < 65 years (n = 191) | Reference | 0.003 |  |  | Reference | 0.017 |  |  |
 ≥ 65 years (n = 159) | 1.413 (1.126–1.773) |  |  |  | 1.333 (1.053–1.687) |  |  |  |
Grade | ||||||||
 III (n = 236) | Reference | 0.106 |  |  | Reference | 0.197 |  |  |
 IV (n = 114) | 1.223 (0.958–1.559) |  |  |  | 1.181 (0.917–1.521) |  |  |  |
Tumor size | ||||||||
 < 2 cm (n = 4) | Reference | 0.062 |  |  | Reference | 0.48 |  |  |
 2–4 cm (n = 96) | 0.739 (0.270–2.025) | 0.557 |  |  | 0.698 (0.254–1.915) | 0.485 |  |  |
 > 4 cm (n = 152) | 0.645 (0.238–1.750) | 0.389 |  |  | 0.615 (0.226–1.670) | 0.34 |  |  |
 Unknown (n = 98) | 0.928 (0.340–2.531) | 0.884 |  |  |  |  |  |  |
Tumor location | ||||||||
 Head/overlapping/body (n = 205) | Reference | 0.001 | Reference | 0.03 | Reference | 0.002 | Reference | 0.045 |
 Tail (n = 80) | 0.609 (0.456–0.815) | 0.001 | 0.699(0.520–0.938) | 0.017 | 0.600 (0.443–0.811) | 0.001 | 0.685 (0.504–0.929) | 0.015 |
 Unknown(n = 65) | 1.177 (0.871–1.590) | 0.289 | 1.094(0.809–1.482) | 0.559 | 1.069 (0.777–1.470) | 0.682 | 0.999 (0.725–1.376) | 0.995 |
Lymph node metastases | ||||||||
 No (n = 14) | Reference | 0.001 |  |  | Reference | 0.003 |  |  |
 Yes (n = 46) | 0.936 (0.479–1.971) | 0.936 |  |  | 1.151 (0.529–2.501) | 0.723 |  |  |
 Unknown(n = 290) | 1.777 (0.941–3.353) | 0.076 |  |  | 2.022 (0.997–4.103) | 0.051 |  |  |
Chemotherapy | ||||||||
 No (n = 129) | Reference | 0.003 | Reference | < 0.001 | Reference | 0.01 | Reference | < 0.001 |
 Yes (n = 221) | 0.705 (0.558–0.890) |  | 0.596(0.468–0.760) |  | 0.726 (0.569–0.925) |  | 0.624 (0.485–0.803) |  |
Year of diagnosis | ||||||||
 < 2010 (n = 212) | Reference | 0.062 |  |  | Reference | 0.102 |  |  |
 ≥ 2010 (n = 138) | 0.791 (0.619–1.012) |  |  |  | 0.810 (0.629–1.043) |  |  |  |
Primary surgery | ||||||||
 No (n = 300) | Reference | < 0.001 | Reference | < 0.001 | Reference | < 0.001 | Reference | < 0.001 |
 Yes (n = 50) | 0.479 (0.337–0.682) |  | 0.427(0.294–0.621) |  | 0.487 (0.337–0.703) |  | 0.440 (0.298–0.648) |  |